Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa, Busulfan, and Melphalan with Stem Cell Transplant in Multiple Myeloma
NCT00003146Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 1997
- Primary completion
- Jun 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, melphalan, thiotepa in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Nov 1997; status: completed.
02
Drugs
busulfanmelphalanthiotepa
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003146.